TWD
ONC

True Wealth Design’s BeOne Medicines Ltd ONC Stock Holding History

True Wealth Design’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$570 Buy
2
+1
+100% +$295 ﹤0.01% 2166
2026
Q1 		$297 Sell
1
-5
-83% -$1.62K ﹤0.01% 2223
2025
Q4 		$1.82K Buy
6
+1
+20% +$327 ﹤0.01% 1486
2025
Q3 		$1.7K Buy
+5
New +$1.52K ﹤0.01% 1526

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

True Wealth Design's ONC Position: Q2 2026 in Review

True Wealth Design increased its BeOne Medicines Ltd (ONC) stake by 100% in Q2 2026, buying an estimated $295 and bringing the position to 2 shares worth $570. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

True Wealth Design first reported a position in ONC in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.82K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • True Wealth Design held 2 shares of BeOne Medicines Ltd worth $570 as of Q2 2026.
  • True Wealth Design bought 1 BeOne Medicines Ltd share in Q2 2026, an estimated $295.
  • BeOne Medicines Ltd made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2166 holding.
  • True Wealth Design first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 4 quarters since.
  • True Wealth Design's BeOne Medicines Ltd position peaked at $1.82K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.